AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow purchase articles
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in AJPH
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Get other permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (39)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bentley, M. E.
Right arrow Articles by Celentano, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bentley, M. E.
Right arrow Articles by Celentano, D. D.
July 2004, Vol 94, No. 7 | American Journal of Public Health 1159-1164
© 2004 American Public Health Association


RESEARCH AND PRACTICE

Acceptability of a Microbicide Among Women and Their Partners in a 4-Country Phase I Trial

Margaret E. Bentley, PhD, Andrew M. Fullem, MSPH, Elizabeth E. Tolley, MA, Clifton W. Kelly, MS, Neelam Jogelkar, MS, Namtip Srirak, PhD, Liness Mwafulirwa, RN, Gertrude Khumalo-Sakutukwa, MSW, MSc and David D. Celentano, ScD, MHS

Margaret E. Bentley is with the Carolina Population Center, University of North Carolina, Chapel Hill, NC. Andrew M. Fullem is with John Snow Inc, Boston, Mass. Elizabeth E. Tolley is with Family Health International, Durham, NC. Clifton W. Kelly is with the Fred Hutchinson Cancer Center, Seattle, Wash. Neelam Jogelkar is with the National AIDS Research Institute, Pune, India. Namtip Srirak is with the Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand. Liness Mwafulirwa is with the Johns Hopkins University College of Medicine Research Project, Blantyre, Malawi. Gertrude KhumaloSakutukwa is with the Center for AIDS Prevention, University of California, San Francisco. David D. Celentano is with the Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Md.

Correspondence: Requests for reprints should be sent to Margaret E. Bentley, Carolina Population Center Department of Nutrition, 123 West Franklin St, Suite 308B, Chapel Hill, NC 27516 (e-mail: pbentley{at}unc.edu).

Objectives. We analyzed qualitative and quantitative data for 98 HIV-negative, low-risk women in Malawi, Zimbabwe, India, and Thailand who participated in a safety and acceptability study of BufferGel, a vaginal microbicide to determine the across-country acceptability of vaginal microbicides among women and their partners.

Methods. Quantitative survey data were collected at 7 and 14 days after use among enrolled women, and exit interviews were conducted with women and their partners in separate focus group discussions.

Results. Acceptability was high in all sites (73% of women approved of the microbicide). Women in Africa, where HIV infection rates are highest, were virtually unanimous in their desire for such a product, suggesting that an individual’s perception of being at risk for HIV will outweigh concerns about side effects, problems applying a product, or other factors, when products are shown to be efficacious. But men and women reported that use, which was kept secret from an intimate partner, would be difficult and might "break the trust" of a relationship.

Conclusions. Acceptability research across diverse settings through all stages of microbicide research, development, and postlicensure dissemination can help maximize acceptability and use.


Related articles in AJPH:

HIV and Women: When Words Speak Louder Than Actions
Michael Gross
AJPH 2004 94: 1079-1080. [Extract] [Full Text]  



This article has been cited by other articles:


Home page
Am. J. Public HealthHome page
J. A. Higgins and J. S. Hirsch
Pleasure, Power, and Inequality: Incorporating Sexuality Into Research on Contraceptive Use
Am J Public Health, October 1, 2008; 98(10): 1803 - 1813.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Microbiol.Home page
B. J. Wood, P. Rizzo-Price, J. Holden, A. Hardick, T. C. Quinn, and C. A. Gaydos
The Microbicide Tenofovir Does Not Inhibit Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples
J. Clin. Microbiol., February 1, 2008; 46(2): 763 - 765.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Public HealthHome page
E. E. Tolley and L. J. Severy
Integrating Behavioral and Social Science Research Into Microbicide Clinical Trials: Challenges and Opportunities
Am J Public Health, January 1, 2006; 96(1): 79 - 83.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
Minerva
BMJ, July 24, 2004; 329(7459): 240 - 240.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Public Health Association